#visceral fat

2 stories

#alk7 #belly fat loss #fasting #finance #glp-1 #intermittent fasting #licensing #markets #metabolism #molecular target #pharmaceuticals #rnai

Roche Bets $1.16 Billion on RNAi Weight-Loss Therapy
Roche secures $1.16 billion RNAi weight-loss drug deal with Rona Therapeutics.
BigGo Finance · 1m
Fasting window triples belly fat loss without calorie cuts
A UC San Diego study found that eating within a 10-hour daily window burns three times more visceral belly fat than traditional calorie counting.
Woman's World · 1m